A massive study of more than 120,000 older adults suggests that common osteoporosis drugs may reduce the risk of Alzheimer’s ...

Prolia (denosumab), a medication prescribed to treat osteoporosis, will now come with a boxed warning that taking it could increase a patient’s risk of developing low blood calcium levels, a condition ...

The U.S. Food and Drug Administration on Friday issued a boxed warning on the prescribing information for Amgen's (NASDAQ:AMGN) osteoporosis drug, Prolia (denosumab). Boxed warnings are the most ...

Sandoz has obtained the Food and Drug Administration’s clearance for Wyost (denosumab-bbdz) and Jubbonti (denosumab-bbdz), the only FDA-approved denosumab biosimilars, to treat all indications of ...

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Osteoporosis Drugs Market Size, Share, & Trends Analysis Report by Drug Class (Branded, Generics), Type (Bisphosphates, Parathyroid Hormone Therapy), ...

Dublin, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The "Osteoporosis Drugs Market, Size, Share, Global Forecast 2023-2030, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report ...

Osteoporosis quietly weakens bones until a minor stumble, or sometimes no obvious trauma at all, produces a fracture. Among the most feared consequences are breaks in the vertebrae of the spine, which ...